Browse Drug Recalls
1,141 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,141 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,141 FDA drug recalls in 2017.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jul 12, 2017 | Halyard 24-Hour Oral Care Kit q2, contains 2x15 mL Unit Dose Cups 0.12% Chlor... | Crystallization with subpotent out of specification assay results for chlorhexidine. | Class III | Akorn Inc |
| Jul 11, 2017 | Pravastatin Sodium Tablets, USP, 10 mg, packaged in a) 90-count bottles (NDC ... | Failed Impurities/Degradation Specifications: high out of specification results for related impur... | Class III | Dr. Reddy's Laboratories, Inc. |
| Jul 6, 2017 | 0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Container, Rx Only, Baxt... | Lack of Assurance of Sterility: Bags have the potential to leak. | Class II | Baxter Healthcare Corporation |
| Jul 6, 2017 | 5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Rx only, Baxte... | Lack of Assurance of Sterility: Bags have the potential to leak. | Class II | Baxter Healthcare Corporation |
| Jul 6, 2017 | Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Onl... | Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-re... | Class III | Hospira Inc., A Pfizer Company |
| Jul 6, 2017 | 0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Ba... | Lack of Assurance of Sterility: Customer complaints for leaking bags. | Class II | Baxter Healthcare Corporation |
| Jul 5, 2017 | ULTRA-STEN Rapid Size and Strength capsules, 10 mgs, 90 count bottle, Hardcor... | Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or Dymethazine. | Class I | HARDCORE FORMULATIONS |
| Jul 5, 2017 | D-ZINE Rapid Size and Strength capsules, 10mgs, 90 count bottle, Hardcore For... | Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or Dymethazine. | Class I | HARDCORE FORMULATIONS |
| Jul 5, 2017 | Carbamazepine Oral Suspension, USP. 100 mg/5 mL, 5 mL Unit Dose Cups, Rx Only... | Labeling Error: Label mix-up. Products' unit dose cups are correctly labeled, but the product ca... | Class II | Precision Dose Inc. |
| Jun 29, 2017 | Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle... | Failed Impurities/Degradation Specifications: out of specification test results for related comp... | Class III | Teva Pharmaceuticals USA |
| Jun 29, 2017 | Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg 30 tablets per bot... | Failed Impurities/Degradation Specifications: out of specification test results for related comp... | Class III | Teva Pharmaceuticals USA |
| Jun 28, 2017 | Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only,... | Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being ... | Class III | Valeant Pharmaceuticals North America LLC |
| Jun 28, 2017 | parodontax WHITENING (Stannous fluoride) Daily Fluoride Anticavity and Antigi... | Presence of Foreign Substance: possibility of the presence of metal in the product. | Class II | GSK Consumer Healthcare |
| Jun 26, 2017 | Lactulose Solution, USP, 20 g/30 mL, dose cups delivers 30 mL packaged 50-uni... | Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification. | Class II | VistaPharm, Inc. |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection 20 mMol in 100 mL in 15... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 5% Dextrose Injection, 30 mMol 500 mL in 500 mL Intrav... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 30 mMol in a) 250 mL i... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 7.5 mMol in 100 mL in ... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection 15 mMol in a) 100 mL in... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 5% Dextrose Injection, 15 mMol in 250 mL in 250 mL Int... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 5% Dextrose Injection, 9 mMol in 50 mL in 50 mL Intrav... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 40 mMol in 250 mL in 2... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 5% Dextrose Injection, 7.5 mMol in 100 mL in 150 mL In... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Lactulose Solution, USP, 10 g/15 mL, dose cups delivers 15 mL packaged in 50-... | Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification. | Class II | VistaPharm, Inc. |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 10 mMol in a) 100 mL i... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 9 mMol in 100 mL in 15... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Potassium PHOSphate in 0.9% Sodium Chloride Injection, 7 mMol in 100 mL in 15... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 26, 2017 | Succinylcholine Chloride Injection (Preserved) 20 mg per mL, 200 mg per 10 mL... | Lack of Assurance of Sterility; media fill failure at manufacturer | Class II | PharMedium Services, Llc |
| Jun 23, 2017 | Curcumin Emulsion 10mg/ml Injection, Sterile 10 mL Multiple Dose Vial, For Sl... | Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a misl... | Class II | ImprimisRx CA, Inc., dba ImprimisRx |
| Jun 23, 2017 | Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Dr... | Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a misl... | Class II | ImprimisRx CA, Inc., dba ImprimisRx |
| Jun 23, 2017 | Timolol-Latanoprost PF Solution (0.5-0.005)%, Ophthalmic Drops, Sterile 5ml B... | Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a misl... | Class II | ImprimisRx CA, Inc., dba ImprimisRx |
| Jun 23, 2017 | Latanoprost PF Solution, 0.005%, Ophthalmic Drops in Sterile 5ml Bottles, Com... | Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a misl... | Class II | ImprimisRx CA, Inc., dba ImprimisRx |
| Jun 22, 2017 | Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, M... | Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 mon... | Class III | Lupin Pharmaceuticals Inc. |
| Jun 22, 2017 | Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 30 mmol in NS ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Jun 22, 2017 | Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 15 mmol in NS ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Jun 22, 2017 | Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 20 mmol in NS ... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Jun 22, 2017 | MAN OF STEEL capsules, 3000mgs/grain, 1-count packets, Packaged for: One Drop... | Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sild... | Class I | Vitility |
| Jun 22, 2017 | QUELICIN (Succinylcholine Chloride) Injection, USP 20 mg/mL in a) 5 mL vial (... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 10 mMol (14.67 mEq K... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol (44 mEq ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 21, 2017 | Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) ... | Lack of sterility assurance | Class II | SCA Pharmaceuticals |
| Jun 19, 2017 | Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, ... | Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blist... | Class II | Apace KY LLC |
| Jun 19, 2017 | Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe. IV Use Only.... | Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier | Class II | Fagron Compounding Services LLC dba Fagron Ster... |
| Jun 19, 2017 | Amantadine HCl Capsules, USP, 100 mg, Rx Only, 50 Capsules (5x10) Unit Dose ... | Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blist... | Class II | Apace KY LLC |
| Jun 16, 2017 | Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 16, 2017 | Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 07... | Cross Contamination With Other Product: Imipramine | Class III | Sandoz Incorporated |
| Jun 16, 2017 | Clindamycin Injection USP; 300 mg/2 mL (150 mg/mL). 2 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 16, 2017 | Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose ADD-VANT... | Lack of Assurance of Sterility | Class II | Alvogen, Inc |
| Jun 16, 2017 | Ibuprofen Tablets, USP 600 mg, 500-count bottle (Capsule Shaped), Rx only, Ma... | Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contai... | Class II | Time-Cap Laboratories, Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.